Adverum Biotechnologies, Inc. Business Operations Contracts & Agreements
12 Contracts & Agreements
- Collaboration Agreements (4 contracts)
- Cooperation Agreements (1)
- Indemnification Agreements (2)
- Sales Agreements (1)
- Services Agreements (2)
- Voting Agreements (2)
- Sales Agreement, dated May 11, 2023 (Filed With SEC on May 11, 2023)
- Form of Indemnification Agreement for Directors and Executive Officers (Filed With SEC on May 28, 2020)
- Cooperation Agreement, dated as of May 1, 2019, among Adverum Biotechnologies, Inc., The Sonic Fund II, L.P. and Lawrence Kam (Filed With SEC on May 2, 2019)
- Amendment to Collaboration, Option and License Agreement with Editas Medicine, Inc., dated January 25, 2018 (Filed With SEC on March 6, 2018)
- COLLABORATION, OPTION AND LICENSE AGREEMENT (Filed With SEC on November 8, 2016)
- Amended and Restated Master Services Agreement (Filed With SEC on August 9, 2016)
- SUPPORT AND VOTING AGREEMENT (Filed With SEC on February 1, 2016)
- ACQUISITION AGREEMENT by and among AVALANCHEBIOTECHNOLOGIES, INC., ANNAPURNA THERAPEUTICS SAS, THE CONTRIBUTORS, and SHAREHOLDER REPRESENTATIVE SERVICES LLC as the CONTRIBUTORS... (Filed With SEC on February 1, 2016)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT By and Between AVALANCHEBIOTECHNOLOGIES, INC. and REGENERON PHARMACEUTICALS, INC. Dated as of May 1, 2014 (Filed With SEC on July 29, 2014)
- INDEMNIFICATION AGREEMENT (Filed With SEC on July 18, 2014)
- AVALANCHE BIOTECHNOLOGIES, INC. AMENDED AND RESTATED VOTING AGREEMENT (Filed With SEC on July 18, 2014)
- RESEARCH COLLABORATION AND LICENSE AGREEMENT By and Between AVALANCHEBIOTECHNOLOGIES, INC. and REGENERON PHARMACEUTICALS, INC. Dated as of May 1, 2014 (Filed With SEC on June 30, 2014)
